Table 1.

Clinicopathological characteristics

Variable	Number (%)/Median, IQR (P25, P75), range
Female/male, n (%)	30 (56.60%)/23 (43.40%)
Age, years	63.00, 16.50 (53.00, 69.50), 24.00–89.00
Body weight, kg	58.10, 9.25 (53.87, 63.12), 41.00–85.80
BMI (kg/m2)	21.75, 4.38 (19.53, 23.90), 18.25–30.25
PET/CT scan post-injection time, min	56.00, 17.50 (50.5, 68.00), 45.00–88.00
Blood glucose level at time of injection, mg/dl	113.50, 23.96 (104.04, 127.91), 73.80–185.40
Tumor length, mm	18.50, 18.30 (11.70, 30.00), 3.20–91.50
The source of malignant tumors
Head and neck	14 (23.33%)
Lung	9 (15.00%)
Gastrointestinal system	13 (21.67%)
Lymphatic system	9 (15.00%)
Bone	4 (6.67%)
Urinary system	11 (18.33%)